Your browser doesn't support javascript.
loading
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study.
Tiu, Bruce C; Zubiri, Leyre; Iheke, James; Pahalyants, Vartan; Theodosakis, Nicholas; Ugwu-Dike, Pearl; Seo, Jayhyun; Tang, Kimberly; Sise, Meghan E; Sullivan, Ryan; Naidoo, Jarushka; Mooradian, Meghan J; Semenov, Yevgeniy R; Reynolds, Kerry L.
Afiliação
  • Tiu BC; Harvard Medical School, Boston, Massachusetts, USA.
  • Zubiri L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Iheke J; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Pahalyants V; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Theodosakis N; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Ugwu-Dike P; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Seo J; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Tang K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Sise ME; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Sullivan R; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Naidoo J; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Mooradian MJ; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Semenov YR; Beaumont RCSI Cancer Centre, Beaumont Hospital and the RCSI University of Health Sciences, Dublin, Ireland.
  • Reynolds KL; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Immunother Cancer ; 10(6)2022 06.
Article em En | MEDLINE | ID: mdl-35705313
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos